Sub-chronic dietary tryptophan depletion - An animal model of depression with improved face and good construct validity

Journal of Psychiatric Research

Volumn 46, Issue 2, 2012, Pages 239-247

  Franklin, M ^a   Bermudez, I ^a   Murck, H ^d,e,f   Singewald, N ^b,c   Gaburro, S ^b,c,g  

^a OXFORD BROOKES UNIVERSITY   (United Kingdom)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d BRISTOL MYERS SQUIBB   (United States)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f Dept of Stat and Clin Programming   (United States)

^g UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Aldosterone; Behaviour; Corticosterone; Kynurenine; Serotonin; Tryptophan depletion

Indexed keywords

ALDOSTERONE; BINDING PROTEIN; BMAX PROTEIN; CORTICOSTERONE; KYNURENIC ACID; KYNURENINE; PAROXETINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL ANALYSIS; CONSTRUCT VALIDITY; CONTROLLED STUDY; DEPRESSION; FACE VALIDITY; FORCED SWIMMING TEST; HORMONE RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT GAIN; WEIGHT REDUCTION;

ALDOSTERONE; ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; BRAIN; CALCIUM-BINDING PROTEINS; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOSTERONE; DEPRESSION; DIET; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; KYNURENIC ACID; KYNURENINE; MALE; NERVE TISSUE PROTEINS; PAROXETINE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SEROTONIN UPTAKE INHIBITORS; SWIMMING; TIME FACTORS; TRITIUM; TRYPTOPHAN;

EID: 84856007348     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.10.003     Document Type: Article

References (81)

1. Anisman H., Ravindran A.V., Griffiths J., Merali Z. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Molecular Psychiatry 1999, 4:182-188.
2. Badawy A.A., Douherty D.M., Richard D.M. Specifity of the acute tryptophan and tyrosine plus phenylalanine depletion and loading tests 1. Review of biochemical and poor specificity of current amino acid formulations. International Journal of Tryptophan Research 2010, 3:23-34.
3. Baumann A., Heitmann S., Bubendorff V., Himmerich H. [Laboratory changes in anorexia nervosa]. Praxis 2010, 99:661-667.
4. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., et al. Antidepressant effects of ketamine in depressed patients. Biological Psychiatry 2000, 47:351-354.
5. Blokland A., Lieben C., Deutz N.E. Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat. Journal of Psychopharmacology 2002, 16:39-49.
6. Boullin D.J. Behaviour of rats depleted of 5-Hydroxytryptamine by feeding a diet free of tryptophan. Psychopharmacologia 1963, 5:28-38.
7. Boullin D.J. Observations on the significance of 5-Hydroxytryptamine in relation to the peristaltic reflex of the rat. British Journal of Pharmacology and Chemotherapy 1964, 23:14-33.
8. 2 receptors are partially involved in the relationship between renin release and delta relative power. Journal of Endocrinology Investigation 1996, 19:556-562.
9. Brown C.M., Fletcher P.J., Coscina D.V. Acute amino acid loads that depelte brain serotonin fail to alter behaviour. Pharmacoogy, Biochemistry and Behaviour 1998, 59:115-121.
10. 2A receptor binding in the rat. Psychopharmacology 2007, 190:497-506.
11. Casper R.C., Swann A.C., Stokes P.E., Chang S., Katz M.M., Garver D. Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder. Acta Psychiatrica Scandinavica 1987, 75:243-250.
12. Chi J.D., Odontiadis J., Franklin M. Simultaneous determination of catecholamines in rat brain tissue by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications 1999, 731:361-367.
13. Clemens J.A., Bennett D.R., Fuller R.W. The effect of a tryptophan-free diet on prolactin and corticosterone release by serotonergic stimuli. Hormone and Metabolism Research 1980, 12:35-38.
14. Cowen P.J. Serotonin and depression: pathophysiological mechanism or marketing myth?. Trends in Pharmacological Sciences 2008, 29:433-436.
15. Cowen P.J. Not fade away: the HPA axis and depression. Psychological Medicine 2010, 40:1-4.
16. Delgado P.L. The tryptophan depletion challenge test in medical research: unresolved issues and broader implications for the use of physiological challenges to investigate and categorise disease. Biological Psychiatry 2011, 69:718-719.
17. Delgado P.L., Charney D.S., Price L.H., Landis H., Heninger G.R. Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. Life Sciences 1989, 45:2323-2332.
18. D'Souza D.N., Zhang Y., Garcia F., Battaglia G., Van de Kar L.D. Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan- deficient diet. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 2004, 286:R390-R397.
19. Emanuele E., Geroldi D., Minoretti P., Coen E., Politi P. Increased plasma aldosterone in patients with clinical depression. Archives of Medical Research 2005, 36:544-548.
20. Fernstrom J.D., Wurtman R.J. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 1972, 178:414-416.
21. Franklin M. Determination of nefazodone and its metabolites in plasma by high-performance liquid chromatography with coulometric detection. Journal of Pharmaceutical and Biomedical Analysis 1993, 11:1109-1113.
22. Franklin M., Odontiadis J. Effects of treatment with chromium picolinate on peripheral amino acid availability and brain monoamine function in the rat. Pharmacopsychiatry 2003, 36:176-180.
23. Franklin M., Cowen P.J., Craven R.D. The effect of a low tryptophan diet on brain 5-HT metabolism and 5-HT-mediated neuroendocrine responses in the male rat. Journal of Psychopharmacology 1995, 9(4):336-341.
24. Franklin M., Craven R.D., Cowen P.J. Effect of castration with hormone replacement on the plasma prolactin responses to neuroendocrine challenge with i.v. mCPP in the male rat following a low tryptophan diet. Journal of Psychopharmacology 1996, 10:53-63.
25. Franklin M., Campling G., Clement E.M., Cowen P.J., Craven R.D. Effect of long-term TRP depletion on plasma TRP and triglycerides, brain TRP,5-HT and 5-HIAA. Journal of Psychopharmacology 1996, 10:A34.
26. Franklin M., Craven R.D., Dowling B., Campling G., Elliott J.M., Cowen P.J. Effect of a long-term low tryptophan diet on the prolactin responses to the 5-HT1A and 5-HT2C agonists, 8-OH-DPAT and mCPP in the male rat. Journal of Psychopharmacology 1999, 13:58-63.
27. Gabbay V., Liebes L., Katz Y., Liu S., Mendoza S., Babb J.S., et al. The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study. Progress in Neuropsychopharmaology Biological Psychiatry 2010, 34(1):37-44.
28. Gál E.M., Sherman A.D. L-kynurenine: its synthesis and possible regulatory function in brain. Neurochemical Research 1980, 5:223-239.
29. Geerling J.C., Kawata M., Loewy A.D. Aldosterone-sensitive neurons in the rat central nervous system. The Journal of Comparative Neurology 2006, 494:515-527.
30. Ghasemi M., Raza M., Dehpour A.R. NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test. Journal of Psychopharmacology 2010, 24:585-594.
31. Gil-Ad I., Zambotti F., Carruba M.O., Vicentini L., Muller E.E. Stimulatory role for brain serotonergic system on prolactin secretion in the male rat. Proceedings of the Society of Experimental Biology and Medicine 1976, 151:512-518.
32. Grahame-Smith D.G. Studies invivo on the relationship between brain tryptophan, brain 5- HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L- tryptophan. The Journal of Neurochemistry 1971, 18:1053-1066.
33. Grippo A.J., Johnson A.K. Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 2009, 12:1-21.
34. Guimaraes R.B., Telles M.M., Coelho V.B., Mori R.C., Nascimento C.M., Ribeiro E.B. Adrenalectomy abolishes the food-induced hypothalamic serotonin release in both normal and monosodium glutamate-obese rats. Brain Research Bullettin 2002, 58:363-369.
35. Hallberg L., Westrin A., Isaksson A., Janelidze S., Traskman-Bendz L., Brundin L. Decreased aldosterone in the plasma of suicide attempters with major depressive disorder. Psychiatry Research 2010.
36. Hlavacova N., Wes P.D., Ondrejcakova M., Flynn M.E., Poundstone P.K., Babic S., Murck H., Jezova D. Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder. International Journal of Neuropsychopharmacology 2011, 4:1-19.
37. Hrdina P.D., Bakish D., Ravindran A., Chudzik J., Cavazzoni P., Lapierre Y.D. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry Research 1997, 66:73-85.
38. Iosifescu D.V., Bolo N.R., Nierenberg A.A., Jensen J.E., Fava M., Renshaw P.F. Brain bioenergetics and response to triiodothyonine augmentation in major depressive disorder. Biological Psychiatry 2008, 63:1127-1134.
39. Jans L.A., Korte-Bouws G.A., Korte S.M., Blokland A. The effects of acute tryptophan depletion on affective behaviour and cognition in Brown Norway and Sprague Dawley rats. Journal of Psychopharmacology (Oxford, England) 2010, 24:605-614.
40. Johnson A.K., Grippo A.J. Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. Journal of Physiology and Pharmacology 2006, 57(11):5-29.
41. Kaye C.M., Haddock R.E., Langley P.F., Mellows G., Tasker T.C., Zussman B.D., et al. Areview of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatrica Scandinavica Supplementum 1989, 350:60-75.
42. Krassas G.E. Endocrine abnormalities in anorexia nervosa. Pediatric Endocrinology Reviews 2003, 1:46-54.
43. Laugeray A., Launay J.M., Callebert J., Surget A., Belzung C., Barone P.R. Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: focus on individual differences. Pharmacological Biochemistry and Behaviour 2011, 98(1):161-168.
44. Li N., Liu R.B., Dwyer J.M., Banasr M., Lee B., Son H., Li X.Y. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioural and synaptic deficits caused by chronic stress exposure. Bilogical Psychiatry 2011, 69(8):754-761.
45. Lieben C.K., van Oorsouw K., Deutz N.E., Blokland A. Acute tryptophan depletion induced by a gelatin-based mixture impairs object memory but not affective behavior and spatial learning in the rat. Behavioral Brain Research 2004, 151:53-64.
46. Machado-Viera R., Salvadore G., Ibrahim L.A., Diaz-Granados N., Zarate C.A. Targeting glutamatergic signalling for the development of novel therapeutics for mood disorders. Current Pharmaceutical Design 2009, 15:1595-1611.
47. Maes M., Leonard B.E., Myint A.M., Kubera M., Verkerk R. The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Progress in Neuropsychopharmacology and Biological Psychiatry 2011, 35(3):702-721.
48. Meyer J.H., Kapur S., Eisfeld B., Brown G.M., Houle S., DaSilva J., et al. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. American Journal of Psychiatry 2001, 158:78-85.
49. Muigg P., Hoelzl U., Palfrader K., Neumann I., Wigger A., Landgraf R., et al. Altered brain activation pattern associated with drug-induced attenuation of enhanced depression- like behavior in rats bred for high anxiety. Biological Psychiatry 2007, 61:782-796.
50. Muller N., Schwarz M.A. Psychoneuroimmunological perspectives to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders. European Archives of Psychiatry Clinical Neuroscience 2008, 258:97-106.
51. Muller N., Myint A.M., Schwartz M.J. The impact of neuroimmune dysregulation and neurotoxicity in psychiatric disorders - relation to drug treatment. Dialogues in Clinical Neuroscience 2009, 11(3):319-332.
52. Murck H. Magnesium and affective disorders. Nutritional Neuroscience 2002, 5:375-389.
53. Murck H. Atypical depression spectrum disorder - neurobiology and treatment. Acta Neuropsychiatrica 2003, 15(4):227-241.
54. Murck H., Held K., Ziegenbein M., Kunzel H., Koch K., Steiger A. The renin-angiotensin- aldosterone system in patients with depression compared to controls-a sleep endocrine study. BMC Psychiatry 2003, 3:15.
55. Murck H., Uhr M., Ziegenbein M., Kunzel H., Held K., Antonijevic I.A. Renin-angiotensin-aldosterone system, HPA-axis and sleep-EEG changes in unmedicated patients with depression after total sleep deprivation. Pharmacopsychiatry 2006, 39:23-29.
56. Myint A.M., Kim Y.K., Verkerk R., Scharpe S., Steinbusch H., Leonard B. Kynurenine pathway in major depression: evidence of impaired neuroprotection. The Journal of Affective Disorders 2007, 98:143-151.
57. Nemeroff C.B. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. The Journal of Clinical Psychiatry 1989, 50(Suppl. 13-20). discussion 21-12.
58. Nemeroff C.B., Mayberg H.S., Krahl S.E., McNamara J., Frazer A., Henry T.R., et al. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 2006, 31:1345-1355.
59. Lapin I. Neurokynurenines (NEKY) as common neurochemical links of stress and anxiety. Advances Experimental Medicine Biolology 2003, 527:121-125.
60. Pollak D.D., Rey C.E., Monje F.J. Rodent models in depression research: classical strategies and new directions. Annals of Medicine 2010, 42:252-264.
61. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
62. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 2006, 27:24-31.
63. Rapkin A.J., Sorger S.N., Winer S.A. Drospirenone/ethinyl estradiol. Drugs Today (Barc) 2008, 44:133-145.
64. Saavedra J.M., Ando H., Armando I., Baiardi G., Bregonzio C., Juorio A., et al. Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists. Regulation of Peptides 2005, 128:227-238.
65. Singewald N. Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mapping. Neuroscience Biobehaviour Reviews 2007, 31:18-40.
66. Singewald N., Sinner C., Hetzzenauer A., Sartori S.B., Murck H. Magnesium-deficient dietalters depression and anxiety-related behaviour in mice-influence of desimapramine and Hypericum perforatum extract. Neuropharmacology 2004, 47:1189-1197.
67. Song C., Leonard B.E. The olfactory bulbectomised rat as a model of depression. Neuroscience and Biobehavioral Reviews 2005, 29:627-647.
68. Sontia B., Montezano A.C., Paravicini T., Tabet F., Touyz R.M. Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium. Hypertension 2008, 51(4):915-921.
69. Sumiyoshi T., Ichikawa J., Meltzer H.Y. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain. Neuropsychopharmacology 1997, 16:183-190.
70. Tanke M.A., Alserda E., Doornbos B., van der Most P.J., Goeman K., Postema F., et al. Low tryptophan diet increases stress-sensitivity, but does not affect habituation in rats. Neurochemistry International 2008, 52:272-281.
71. Trajkovska V., Kirkegaard L., Krey G., Marcussen A.B., Thomsen M.S., Chourbaji S., et al. Activation of glucocorticoid receptors increases 5-HT2A receptor levels. Experimental Neurology 2009, 218:83-91.
72. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. The American Journal of Psychiatry 2006, 163:28-40.
73. Van Donkelaar E.L., Blokland A., Ferrington L., Steinbusch H.W., Prickaerts J. Mechanism of acute tryptophan depletion: is it only serotonin?. Molecular Psychiatry 2011, 16(7):695-713.
74. Vielhaber K., Riemann D., Feige B., Kuelz A., Kirschbaum C., Voderholzer U. Impact of experimentally induced serotonin deficiency by tryptophan depletion on saliva cortisol concentrations. Pharmacopsychiatry 2005, 38:87-94.
75. Walsh A.E., Oldman A.D., Franklin M., Fairburn C.G., Cowen P.J. Dieting decreases plasma tryptophan and increases the prolactin response to d-fenfluramine in women but not men. Journal of Affective Disorders 1995, 33:89-97.
76. Wang M., Hammarback S., Lindhe B.A., Backstrom T. Treatment of premenstrual syndrome by spiralactone: a double-blind, placebo-controlled study. Acta Obstetricia et gynecologica Scandinavica 1995, 74:803-808.
77. Whittle N., Li L., Chen W.Q., Yang J.W., Simone B., Sartori G.L., Singewald N. Changes inamygdala-hypothalamic protein expression are linked to magnesium restriction-induced depression=like behaviour. Amino Acids 2011, 40(4):1231-1248.
78. Wichers M.C., Koek G.H., Robaeys G., Verkerk R., Scharpe S., Maes M. IDO and interferon- alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Molecular Psychiatry 2005, 10:538-544.
79. Williams J.N., Elvehjem C.A. The effects of tryptophan deficiency upon enzyme activity in the rat. The Journal of Biological Chemistry 1950, 183:531-538.
80. Young S.N. Mechanism of decline in rat brain 5-hydroxytryptamine after induction of liver tryptophan pyrrolase by hydrocortisone: roles of tryptophan catabolism and kynurenine synthesis. British Journal of Pharmacology 1981, 74:695-700.
81. Zarate C., Machado-Viera R., Henter I., Ibrahim L., Diazgranados N., Salvadore G. Glutamtergic modulators: the future of treating mood disorders?. Harvard Reviews of Psychiatry 2010, 18(5):293-303.